1. Required Components of RA Disease Activity Measures for Point-of-Care Clinical Use

2. Disease Activity Cutoffs for ACR-Recommended RA Disease Activity Measure

3. Non-TNF-Targeted DMARDs Approved for RA

4. ROC Trial Non-TNF vs Anti-TNF Treatment of RA After Failure of First Anti-TNF

5. Tofacitinib Meta-Analysis ACR Response Rates

6. ACR20 Response at Week 12 by Prior bDMARD

7. Selected Adverse Events Associated With Non-TNF-Targeted DMARDs

8. RA Response and Monitoring

9. Multidisciplinary Care for RA

10. Abbreviations

11. Abbreviations (cont)